“Thank you for your interest in the company. We are a global advisory firm specializing in cross-border deal flow focused in China’s healthcare industry. The firm is the leading platform to facilitate partnerships to fuse Chinese capital, its large and fast-growing market with US/EU healthcare innovation.
With an experienced team of well-connected industry veterans from all over the world and the largest network in China’s healthcare industry, TPP has become the market expert with the top-notch network to execute and support cross-border transactions involving pharmaceuticals, medical devices and diagnostics.”
Tony Chu, Co-Founder, Partner
In addition to TPP, Mr. Hong is a Managing Director at Legend Capital, focusing on investments in Healthcare. Mr. Hong has rich experience in the pharmaceutical industry and investment in Healthcare. The investment portfolios he has led include: Kawin Technology, Innovent Biologics, PegBio , Baheal Pharmaceutical, Phiskin, Sciwin Biologics, Sinopharm Rfl etc. Prior to Legend Capital, Mr. Hong worked at ShiYu Capital, Nanjing University of Traditional Chinese Medicine, Bayer Healthcare. Mr. Hong holds a Bachelor’s degree from China Pharmaceutical University and a MBA from TongJi University.
Note: Partial List